Glycan analysis provides key information on critical quality attributes that could affect stability, safety and efficacy of a protein therapeutic. Specific needs for understanding the glycosylation profiles change throughout the drug development process, but the requirement for high-resolution glycan information remains the same and is essential to help ensure product quality.

During bioprocess development, high throughput N-glycan analysis is needed to support screening large numbers of samples. In this webinar, discover new strategies to accommodate increasing analytical demands for process analytical labs.

• CE-based high-throughput method for monitoring the glycan profile of biologics
• Developing a reproducible method for released N-Glycan analysis

Presented by:

Brian Wei PhD

Senior Scientist

Sanofi